Pfizer submits application for updated COVID-19 vaccine booster to FDA

Pfizer, BioNTech ask FDA to certify updated COVID-19 vaccine

Drugmakers Pfizer and BioNTech have applied to the US Food and Drug Administration, or FDA, for emergency use authorization of an updated coronavirus vaccine.

Pfizer and BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of age and older

The bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein, which is present in the original Pfizer-BioNTech COVID-19 Vaccine, together with mRNA encoding the spike protein of...

Pfizer Seeks US Authorization of COVID-19 Boosters for Latest Omicron Variants

Pfizer and partner BioNTech announced they have submitted a request to the U.S. Food and Drug Administration (FDA) to authorize a COVID-19 vaccine booster that has been updated to target the newest Omicron subvariants. The request comes after the FDA in June advised COVID-19 vaccine makers to amend their shots to target the two Omicron subvariants BA.4 and BA.5, which are better than ever at dodging immunity from earlier vaccination or infection…

COVID vaccines for fall: Pfizer seeks OK of updated boosters

For now at least, the BA.5 omicron variant currently is causing nearly all COVID-19 infections in the U.S., and much of the world.

COVID vaccines for fall: Pfizer seeks OK of updated boosters

For now at least, the BA.5 omicron variant currently is causing nearly all COVID-19 infections in the U.S., and much of the world.

News Wrap: Pfizer seeks FDA approval for new COVID vaccine targeting omicron subvariants

In our news wrap Monday, Pfizer asked the FDA to authorize a new COVID vaccine targeting omicron subvariants, Dr. Anthony Fauci will step down from his post in December, Russia blamed Ukraine for a deadly car bombing near Moscow, Pakistan police filed terrorism charges against former Prime Minister Imran Khan, flooding hits Texas, and the U.S. and South Korea kicked off military training drills.